Brief: Adocia Announces Positive Topline Study Results

Adocia SA

06/12/2017 17:01

Dec 6 (Reuters) - ADOCIA SA  ADOC.PA : 
    * ADOCIA ANNOUNCES POSITIVE TOPLINE STUDY RESULTS COMPARING 
ULTRA-RAPID INSULIN BIOCHAPERONE LISPRO WITH NOVOLOG AND FIASP 
IN PEOPLE WITH TYPE 1 DIABETES 
    * BIOCHAPERONE LISPRO U100 SHOWED A SIGNIFICANTLY FASTER-OFF 
EFFECT COMPARED TO FIASPAND SIMILAR ULTRA-RAPID ONSET OF ACTION 
    * BIOCHAPERONE LISPRO U100 DISPLAYED FASTER-ON AND 
FASTER-OFF 
METABOLIC EFFECTS COMPARED TO NOVOLOG 
 
Source text for Eikon:  ID:nBw42DFvza  
Further company coverage:  ADOC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))